FAS and cancer: Several studies identified molecules associated with the tumor escape mechanism, such as PD-1/PD-L1, Fas/ FasL, and Decoy receptor 3, which might explain the poor immunogenicity and limitations of the antitumor effects of cancer vaccines alone in patients with advanced HCC (16,17,34,35).